ASL video support to improve cancer screening adherence
Using Community Health Navigators to Advance Cancer Screening Adherence through Videoconferencing for all Americans who use ASL: A Randomized Controlled Trial Study
['FUNDING_U01'] · GALLAUDET UNIVERSITY · NIH-11179483
This project offers ASL-speaking community health navigators by videoconference to help Deaf Americans keep up with recommended cancer screenings.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | GALLAUDET UNIVERSITY (nih funded) |
| Locations | 1 site (WASHINGTON, UNITED STATES) |
| Trial ID | NIH-11179483 on ClinicalTrials.gov |
What this research studies
You would meet with an ASL-proficient community health navigator over video who can explain cancer screening, help schedule appointments, and talk through barriers in clear sign language. Some participants will receive this navigator videoconference support while others receive standard information, and the study will compare who completes recommended screenings. The team enrolls adults who use ASL and follows screening outcomes for breast, cervical, and other age-appropriate cancer screens. The project is led by Gallaudet University and builds on earlier NIH-funded work with experts in cancer outcomes, public health, human factors, and computer science.
Who could benefit from this research
Good fit: Adults who use American Sign Language and are due for age-appropriate cancer screenings (such as breast or cervical screening) are ideal candidates.
Not a fit: People who do not use ASL, are under the study's age criteria, or are already up-to-date with recommended screenings may not benefit from the intervention.
Why it matters
Potential benefit: If successful, this could raise cancer screening and follow-up rates among ASL users and help catch cancers earlier.
How similar studies have performed: Navigator programs have improved screening for hearing patients, and adapting them via ASL videoconferencing is newer but grounded in proven navigator models.
Where this research is happening
WASHINGTON, UNITED STATES
- GALLAUDET UNIVERSITY — WASHINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KUSHALNAGAR, POORNA — GALLAUDET UNIVERSITY
- Study coordinator: KUSHALNAGAR, POORNA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Advanced Cancer, Breast Cancer, Cancer Patient, Cancers, Cervical Cancer